FN2 Earnings Intelligence
Colgate-Palmolive Company ratios (quarterly)
Colgate-Palmolive Company (CL) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,234 | $1,112 | $1,215 | $1,279 | $1,335 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $5,033 | $4,911 | $5,110 | $5,131 | $5,324 | $5,356.3 | $5,348.2 |
| % Growth | - | - | - | - | - | 4.8% | 4.2% |
| Gross Profit | $3,074 | $2,987 | $3,069 | $3,049 | $3,226 | - | - |
| % Margin | 61.1% | 60.8% | 60.1% | 59.4% | 60.6% | - | - |
| EBITDA | - | $1,224 | $1,231 | $1,217 | $1,120 | - | - |
| % Margin | - | 24.9% | 24.1% | 23.7% | 21.0% | - | - |
| Net Income | $737 | $690 | $743 | $735 | $646 | - | - |
| % Margin | 14.6% | 14.1% | 14.5% | 14.3% | 12.1% | - | - |
| Diluted EPS | $0.90 | $0.85 | $0.91 | $0.91 | $0.80 | $0.95 | $0.92 |
| % Growth | - | - | - | - | - | 4.1% | 1.3% |
| Operating Cash Flow | - | $600 | - | - | $747 | - | - |
| CapEx | - | $124 | - | - | $138 | - | - |
| Free Cash Flow | - | $476 | - | - | $609 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $5,033 | $4,911 | $5,110 | $5,131 | $5,324 | $5,356.3 | $5,348.2 |
| Gross Profit | $3,074 | $2,987 | $3,069 | $3,049 | $3,226 | - | - |
| EBITDA | - | $1,224 | $1,231 | $1,217 | $1,120 | - | - |
| Net Income | $737 | $690 | $743 | $735 | $646 | - | - |
| Diluted EPS | $0.90 | $0.85 | $0.91 | $0.91 | $0.80 | $0.95 | $0.92 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,234 | $1,112 | $1,215 | $1,279 | $1,335 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $7,909 | $6,571 | $7,144 | $7,306 | $7,937 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $600 | - | - | $747 |
| Capital Expenditure | - | $124 | - | - | $138 |
| Free Cash Flow | - | $476 | - | - | $609 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 61.1% | 60.8% | 60.1% | 59.4% | 60.6% |
| EBITDA Margin | - | 24.9% | 24.1% | 23.7% | 21.0% |
| Net Margin | 14.6% | 14.1% | 14.5% | 14.3% | 12.1% |
| FCF Margin | - | 9.7% | - | - | 11.4% |
| Diluted EPS Growth | - | - | - | - | - |